Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Transcranial Photobiomodulation (tPBM) for Individuals With Autism Spectrum Disorder and Epileptiform Activity

NCT06352372 is registered in ClinicalTrials.gov with Richard Frye as lead sponsor.

NCT NCT06352372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06352372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Transcranial Photobiomodulation (tPBM) for Individuals With Autism Spectrum Disorder and Epileptiform Activity
Lead sponsor
Richard Frye
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2024
Completion date
February 10, 2026
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, eeg with periodic abnormalities, epilepsy, neurodevelopmental disorders, neurological disorder